跳到主要內容

Oliviero James F III 的 Form 4 申報

Checkpoint Therapeutics, Inc.(CKPT),2022/4/22 申報

申報編號
0001104659-22-049156
申報時間
2022/4/22
交易日
2022/1/1-4/13
申報延遲
111 天遲報
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 8 筆非衍生性交易。公開市場賣出合計 $21.2 萬。交易後 111 天才申報,超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Oliviero James F IIICIK 0001434718董事、高階主管(執行長、總裁、董事)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/1/1COMMON STOCKF扣股繳稅處分−302,777$3.11−$941,636.473,305,433直接
2022/1/6COMMON STOCKF扣股繳稅處分−53,024$2.77−$146,876.483,252,409直接
2022/1/24COMMON STOCKF扣股繳稅處分−143,136$2.19−$313,467.843,109,273直接
2022/1/30COMMON STOCKF扣股繳稅處分−31,972$2.46−$78,651.123,077,301直接
2022/2/24COMMON STOCKF扣股繳稅處分−117,657$1.85−$217,665.452,959,644直接
2022/4/4COMMON STOCKS賣出處分−86,353$1.79F3−$154,571.872,873,291直接
2022/4/5COMMON STOCKS賣出處分−14,030$1.77F4−$24,833.12,859,261直接
2022/4/13COMMON STOCKS賣出處分−21,258$1.51F5−$32,099.582,838,003直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F3

Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.77 to $1.81. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.75 to $1.78. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.51 to $1.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)